YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease

BACKGROUND: Growing body of evidence suggests that the pathogenesis of Alzheimer’s disease (AD), a progressing neurodegenerative condition, is not limited to the neuronal compartment, but also involves various immunological mechanisms. Insoluble Aβ aggregates in the brain can induce the activation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Muszyński, Paweł, Groblewska, Magdalena, Kulczyńska-Przybik, Agnieszka, Kułakowska, Alina, Mroczko, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652033/
https://www.ncbi.nlm.nih.gov/pubmed/28183245
http://dx.doi.org/10.2174/1570159X15666170208124324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652033/
https://www.ncbi.nlm.nih.gov/pubmed/28183245
http://dx.doi.org/10.2174/1570159X15666170208124324

Ejemplares similares